
Flexible asset SRI
DNCA Invest Sustain Alterosa
- Life insurance

Key points
Asset management with a positive social and environmental contribution
- Contributes to sustainable economic transition by investing in issuers judged to be of high quality by the management team on the basis of financial and extra-financial criteria.
- A wealth management approach through an SRI portfolio that seeks to adapt to all market conditions
- Flexible, diversified conviction management in international equities and bonds
Managers comments · October 2026
8 minutes
Equity Portfolio:
In line with previous months—and particularly since the start of the conflict in Iran—October brought its share of surprises, both on the macroeconomic and microeconomic fronts.
Ultimately, the October 28 FOMC meeting had little real impact on the market, as no new guidance was provided (3.75% to 4.0%), despite a relatively hawkish tone from Kevin Warsh. This temporary status quo and the relative strength of the indices (-0.9% for the S&P, +2.0% for the Stoxx 600) partly reflect the robustness of the U.S. economy, with PMIs remaining in expansionary territory, as well as strong consumer resilience, combined with persistently high inflation (U.S. core CPI +2.6% in September). To date, the market is anticipating another 25-basis-point hike in December.
In Europe, economic signals remain more mixed, with a slight improvement in business sentiment in Germany but sluggish domestic growth. The ECB also decided to keep its rates unchanged. France continues to be a cause for concern, as it has been unable to pass its annual budget or take steps to reduce its deficit—estimated at around 5% of GDP—just a few months ahead of the presidential elections. The 10-year OAT yield briefly exceeded 5%, and the spread against the 10-year German bond widened sharply, peaking at 165 basis points at the end of the month—exceeding the all-time high set in 2011 (130 basis points).
October thus saw a significant sector rotation, with a return to favor defensive sectors. The technology sector ended the month mixed, with companies perceived as “AI losers” notably outperforming semiconductors, despite a string of impressive Q3 earnings reports.
Against this backdrop, the fund posted a monthly return of 0.03%, compared to 0.55% for its benchmark index.
Over the month, the top relative outperformers in the portfolio were: Eli Lilly (+18 bps, active weight +0.8%), Galderma (+9 bps, active weight +0.3%), Iberdrola (+9 bps, active weight +1.0%), Nextera (+8 bps, active weight +0.6%), and EssilorLuxottica (+7 bps, active weight +0.3%). Conversely, the worst performers were Schneider Electric (-14 bps, active weight +0.9%), Unicredit (-10 bps, active weight +0.9%), Intesa Sanpaolo (-10 bps, active weight +0.9%), Eaton (-8 bps, active weight +0.6%), and ING (-8 bps, active weight +0.9%).
Among the key portfolio adjustments, we increased our positions in Schneider Electric, Knorr-Bremse, Prysmian, and ASML, and reduced our positions in Johnson Controls, Palo Alto, Veeva Systems, and Xylem. We initiated a new position in the portfolio: Galderma. The Swiss pharmaceutical company specializing in dermatology offers a very attractive growth profile, particularly with its Nemluvio treatment for nodular prurigo and atopic dermatitis (itchy skin). A key catalyst for 2027 is the potential launch of Relfydess in the United States, a cosmetic injectable.
Gross equity exposure stood at 31% at the end of October.
The resilience of the equity markets seems surprising, given certain macroeconomic indicators. The price of a barrel of oil continues to soar ($118 for Brent) despite the resumption of oil flows through the Strait of Hormuz, while the 10-year U.S. Treasury yield is also hovering around 5%. Increased inflationary pressures appear to be here to stay (conflict, sovereignty issues, reshoring, etc.) and are likely to weigh on growth. Nevertheless, growth is holding up for now (+3.4% U.S. GDP in Q3 2026), thanks primarily to the surge in investment in artificial intelligence (estimated to account for one-third of this growth), which is fueling a number of sectors (semiconductors, manufacturing, infrastructure), while generating significant wealth for certain Silicon Valley employees (see Anthropic’s upcoming IPO) and in Korea (memory stocks at record highs). Recent tensions surrounding funding for Neocloud companies (CoreWeave, Nebius), which have reached particularly high levels (15%), prompt us to exercise caution, as do the U.S. midterm elections, which could put the brakes on this trend, potentially leading to more regulation governing the construction of data centers.
Fixed Income Portfolio:
Despite persistent inflation, the pace of rate hikes slowed in October, supporting credit performance. The month ended with central banks maintaining the status quo but confirmed expectations of a rate hike in December to curb rising prices. In the United States, investment-grade bonds gained 2.2% and high-yield bonds 0.6%. Attractive yields are drawing new investors across the entire credit spectrum. However, the technology sector is a cause for concern due to the scale of its investments and financing needs, its higher cost of capital, and significant uncertainty regarding its future profitability.
In Europe, the bond market’s respite allowed investment-grade bonds to gain 0.8%. However, high-yield bonds were impacted by a unwinding of positions and an increase in idiosyncratic risk. They ended the month down 0.7%, with a spread widening of 55 basis points. Market conditions improved over the course of the month, with a return of in s (€51 billion in investment-grade funds and €54 billion in high-yield funds) and a moderation in the primary market linked to the earnings season and more subdued investor appetite (€41 billion in investment-grade issuances and €8.7 billion in high-yield issuances).
In October, Alterosa’s bond portfolio made a positive contribution to the fund’s performance despite the underperformance of high-yield bonds.
Dollar-denominated investments outperformed. In terms of ratings, the highest-rated bonds performed the best, while convertibles, financial subordinated debt, and B-rated bonds weighed on performance. In contrast, hybrid securities made a positive contribution.
The sectors contributing most to performance are healthcare, utilities, transportation, services, and basic materials. Those contributing the least are capital goods, real estate, energy, consumer goods, and insurance.
At the issuer level, the largest contributors to performance are Thermo Fisher (healthcare), Teva (healthcare), Bristol-Myers (healthcare), EDP (utility), and Smith & Nephew (healthcare). The weakest contributors were Schneider Electric (capital goods), whose convertible bond fell following the announcement of the acquisition of PTC despite strong results; Purmo Group (capital goods); Saur (utility), following disappointing half-year results; Unibail-Rodamco-Westfield (real estate); and Domus Vie (healthcare).
During the month, we took profits on the ZF bond and reduced our exposure to the automotive sector. At the end of the month, we participated in the initial public offerings of Saur (utility), which offered an attractive risk premium, and Recordati (healthcare), which was delisted. We remain positive on the credit market. Growth remains solid in the United States and, to a lesser extent, in Europe, and corporate earnings are encouraging. The primary market could remain active—this will be a factor to monitor in the coming months—but issuance volumes are trending upward. Valuations are once again attractive in terms of yield and provide a solid safety cushion in the event of a further widening of spreads. We continue to favor the investment-grade segment and short durations. At the end of the month, bond investments totaled 60.5%, with 38% in investment-grade bonds. The yield is 5% with a duration of 3.9.
NAV
As of 16/11/2026
Risk Indicator
Synthetic risk indicator according to PRIIPS. 1 corresponds to the lowest level and 7 to the highest level.
Risks
- Interest-rate risk
- Credit risk
- Equity risk
- Risk related to investments in emerging markets
- Risk of capital loss
- Risk of investing in derivative instruments as well as instruments embedding derivatives
- Specific Risk linked to ABS and MBS
- Distressed securities risk
- ESG risk
- Risk related to exchange rate
- Specific Risks linked to Convertible, Exchangeable and Mandatory Convertible Bonds
- Specific risks of investing in contingent convertible bonds ("Cocos")
- Sustainability risk
- Bond risk 144A
Performance and volatility
As of 16/11/2026
Past performance is not an indicator of future performance. Management fees are included in performance. The performances are calculated net of any fees by DNCA FINANCE. This is not a capital guarantee fund.
Breakdown by country
As of 30/09/2026
Performance
As of 16/11/2026
- Fund name change, formerly known as DNCA Invest Beyond Alterosa.
Past performance is not an indicator of future performance. Management fees are included in performance. The performances are calculated net of any fees by DNCA FINANCE. This is not a capital guarantee fund.
Portfolio Managers
David Tissandier
Head of Multi-Management
Graduated with a Master’s degree in Economic Engineering with a Finance specialization and a Specialized Master’s in Finance and Market Operations Organization from SKEMA Business School, David is a recognized expert in financial analysis of UCITS.
He began his career in 2000 at Banque du Louvre and then at HSBC Private Bank France as an analyst/portfolio manager, and later as head of a team of three portfolio managers. In 2006, he joined La Française des Placements as a portfolio manager within the diversified management team. In 2016, he became head of the team, leading six analyst-portfolio managers. The team manages €3 billion in assets under management and oversees selection and asset allocation activities for a client base including institutional investors, independent financial advisors, and distribution networks.
In May 2019, he joined DNCA Finance.
Footnotes
* The inception date of the Fund is 17/12/2018.
Legal information
The above information is not a confirmation of any transaction and does not comprise investment advice. Past performances are not a reliable indicator of future performances. Management fees are included in performances. Access to products and services presented may be restricted regarding certain persons or countries. Tax treatment depends on the individual situation of each investor. For full information regarding strategies and fees, please refer to the prospectus, Key Information Document and other regulatory information available on this website or free of charge on demand from the investment management company’s registered offices.
You can access a summary of your rights here.
Information on the fees, commissions or non-monetary benefits : DNCA Finance would like to inform its clients (existing or potential) that within the context of its fund management business, DNCA Finance may receive from or pay to third parties (e.g. introducing brokers, distributors, brokers, asset managers) certain commissions, fees or non-monetary benefits in connection with the provision of investment or ancillary services. Upon request, DNCA Finance may communicate to its clients any additional information relating to these remunerations, commissions or non-monetary benefits.
The Sub-Fund has as its objective sustainable investment within the meaning of Article 9 of SFDR. The Sub-Fund is managed taking into consideration responsible and sustainable principles and aims to be target issuers with a significatively exposure of percentage or their revenues to the 17 Sustainable Development Goals of the United Nations.

